| Current Price | $25.13 | Mkt Cap | $3.8B |
|---|---|---|---|
| Open | $25.34 | P/E Ratio | 49.67 |
| Prev. Close | $25.13 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $25.10 - $26.04 | Volume | 543 |
| 52-Wk Range | $13.86 - $26.64 | Avg. Daily Vol. | 4,414,919 |
A biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases.
| Current Price | $25.13 | Mkt Cap | $3.8B |
|---|---|---|---|
| Open | $25.34 | P/E Ratio | 49.67 |
| Prev. Close | $25.13 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $25.10 - $26.04 | Volume | 543 |
| 52-Wk Range | $13.86 - $26.64 | Avg. Daily Vol. | 4,414,919 |
The best Bull and Bear pitches based on recency and number of recommendations.
Many cancer medicine on trial. strong tieup with Astra for selling and research support. loss recovered compared to last year
It's rather dangerous to red thumb a beaten down cancer or hepatitis biotech, because each one has a finite possibility of rising from the ashes like a Phoenix (or a Pharmasset or Pharmacyclics). Once the market anoints a developmental drug as the… More
Read the most recent pitches from players about ARRY.
Recs
nverdurmen
(< 20)
Submitted: 10/1/2021 6:04:01 PM :
Start Price:
$18.55
NASDAQ:ARRY Score:
+34.17
Solar industry
Recs
Kentuckyfarmer
(< 20)
Submitted: 8/12/2021 9:17:45 PM :
Start Price:
$16.93
NASDAQ:ARRY Score:
+49.99
Finally has things going in the right direction. Had some issues with supply chain in Q1 2021 but seems to have that taken care of and ready to move forward.
Recs
Aiming
(< 20)
Submitted: 8/21/2015 8:49:14 AM :
Start Price:
$5.15
NASDAQ:ARRY Score:
+270.52
Many cancer medicine on trial. strong tieup with Astra for selling and research support. loss recovered compared to last year
Find the members with the highest scoring picks in ARRY.
Haugurafpeningum (24.67) Score: +1,593.44
The Score Leader is the player with the highest score across all their picks in ARRY.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| UncleSachse | < 20 | 10/21/2009 |
|
1Y | $2.09 | +1,102.39% | +302.27% | +800.12 | 0 Comment | |
| EvilUnicorn | 64.93 | 11/17/2009 |
|
5Y | $2.21 | +1,039.68% | +295.49% | +744.19 | 0 Comment | |
| wes29 | 42.20 | 6/10/2011 |
|
3M | $2.40 | +947.08% | +240.43% | +706.66 | 0 Comment | |
| AlpineFirst | < 20 | 3/23/2010 |
|
3Y | $2.47 | +917.41% | +275.48% | +641.93 | 0 Comment | |
| boardwalken65 | 30.53 | 2/10/2012 |
|
3M | $2.65 | +848.30% | +227.03% | +621.28 | 0 Comment | |
| stmbpsak | 74.19 | 10/13/2009 |
|
3Y | $2.47 | +917.41% | +308.30% | +609.11 | 0 Comment | |
|
21popsontop | 73.68 | 1/28/2010 |
|
3Y | $2.51 | +901.20% | +301.68% | +599.51 | 1 Comment |
| taddys | 82.91 | 5/23/2011 |
|
3Y | $2.70 | +830.74% | +232.35% | +598.39 | 0 Comment | |
| ChronicInvestor | < 20 | 10/2/2009 |
|
3Y | $2.45 | +925.71% | +329.98% | +595.74 | 0 Comment | |
| robbg52999 | 39.07 | 10/12/2009 |
|
NS | $2.51 | +901.20% | +307.35% | +593.85 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
